Matteo Trevisan

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Development of a sensitive plasma lenvatinib quantification method and validation in thyroid cancer patients.

Development of a sensitive plasma lenvatinib quantification method and validation in thyroid cancer patients.

Journal: Journal of the Endocrine Society

Published: April 09, 2026

VALIDATION OF THE 2025 ATA RISK STRATIFICATION SYSTEM IN A COHORT OF PATIENTS WITH PAPILLARY THYROID CARCINOMA.

VALIDATION OF THE 2025 ATA RISK STRATIFICATION SYSTEM IN A COHORT OF PATIENTS WITH PAPILLARY THYROID CARCINOMA.

Journal: The Journal of clinical endocrinology and metabolism

Published: February 09, 2026

Determinants of Health-Related Quality of Life in Differentiated and Poorly Differentiated Thyroid Cancer Patients With Structural Incomplete Response: A Multicenter Cross-Sectional Study.

Determinants of Health-Related Quality of Life in Differentiated and Poorly Differentiated Thyroid Cancer Patients With Structural Incomplete Response: A Multicenter Cross-Sectional Study.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: November 21, 2025

Physical activity and systemic treatment outcomes in advanced thyroid cancer.

Physical activity and systemic treatment outcomes in advanced thyroid cancer.

Journal: Endocrine oncology (Bristol, England)

Published: October 20, 2025

Prospective Validation of ATA Risk Score for Papillary Thyroid Microcarcinoma: An ITCO Real-World Study.

Prospective Validation of ATA Risk Score for Papillary Thyroid Microcarcinoma: An ITCO Real-World Study.

Journal: The Journal of clinical endocrinology and metabolism

Published: September 20, 2024

Will the autofluorescence take over inadvertent parathyroidectomy? Results from a multicentre cohort study.

Will the autofluorescence take over inadvertent parathyroidectomy? Results from a multicentre cohort study.

Journal: Updates in surgery

Published: July 25, 2024

Data-driven Thyroglobulin Cutoffs for Low- and Intermediate-risk Thyroid Cancer Follow-up: ITCO Real-world Analysis.

Data-driven Thyroglobulin Cutoffs for Low- and Intermediate-risk Thyroid Cancer Follow-up: ITCO Real-world Analysis.

Journal: The Journal of clinical endocrinology and metabolism

Published: April 26, 2024

Impact of systemic treatments for advanced thyroid cancer on the adrenal cortex.

Impact of systemic treatments for advanced thyroid cancer on the adrenal cortex.

Journal: European thyroid journal

Published: November 27, 2023

Letter to the Editor: Tumor Lysis Syndrome During Selpercatinib Treatment in a Patient with Medullary Thyroid Cancer.

Letter to the Editor: Tumor Lysis Syndrome During Selpercatinib Treatment in a Patient with Medullary Thyroid Cancer.

Journal: Thyroid : official journal of the American Thyroid Association

Published: July 18, 2023

Management of hypertension during lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm.

Management of hypertension during lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm.

Journal: European thyroid journal

Published: April 19, 2023

Endocrine-related adverse conditions induced by tyrosine kinase inhibitors.

Endocrine-related adverse conditions induced by tyrosine kinase inhibitors.

Journal: Annales d'endocrinologie

Published: March 24, 2023

Hypocalcemia During Lenvatinib Treatment for Advanced Thyroid Cancer: Clinical Features and Management in a Real-Life Setting.

Hypocalcemia During Lenvatinib Treatment for Advanced Thyroid Cancer: Clinical Features and Management in a Real-Life Setting.

Journal: Thyroid : official journal of the American Thyroid Association

Published: November 03, 2022

Showing 1-12 of 19

Last Updated: 09/26/2026